A Research on Strategic Alliance in the R Process of Medicine—From the Perspective of Structural Network Analysis—
スポンサーリンク
概要
- 論文の詳細を見る
Due to the advance of life science, pharmaceutical R process shifted targets from low-molecular medicines to biotechnology-based medicines. As a result, pharmaceutical firms became unable to utilize their accumulated knowledge or technology, and have no choice but to develop new medicines by introducing external resources. However, the dependence on external resources produces the risk of being controlled by another organization, from the viewpoint of the resource dependence theory, and so it is considered important to minimize external resources and take more efficient strategies.This paper is focused on the network for technological transfer among pharmaceutical and bio venture companies, from the viewpoint of pharmaceutical companies, analyze and compare the network structure, and discusses effective strategic partnerships for the development of medicines.
- 日本経営診断学会の論文
著者
関連論文
- 医薬品開発における組織間関係に関する一考察 : ―ネットワーク分析を中心に―
- 医薬品開発における戦略的パートナーシップのあり方に関する一考察 : ネットワーク理論における構造的分析の視点から(第7報告)
- 医薬品製造業における環境経営の現状と課題 : 自動車製造業との比較をふまえて (平成16年度修士論文要旨)
- A Research on Strategic Alliance in the R Process of Medicine—From the Perspective of Structural Network Analysis—